Onderneming Jaguar Health Inc Nasdaq
Aandelen
US47008L1061
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Human Health
98,2
%
| 12 | 98,2 % | 10 | 98,2 % | -18,34% |
Animal Health
1,8
%
| 0 | 1,8 % | 0 | 1,8 % | -19,53% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 12 | 100,0 % | 10 | 100,0 % | -18,36% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06-06-13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 01-05-19 |
Chief Tech/Sci/R&D Officer | 60 | 01-05-17 | |
Jonathan Wolin
CMP | Compliance Officer | 62 | 01-11-18 |
Chief Tech/Sci/R&D Officer | 62 | 01-05-21 | |
Peter C. Hodge
IRC | Investor Relations Contact | - | - |
Karen Brunke
PRN | Corporate Officer/Principal | 72 | 09-09-21 |
Ian Wendt
PRN | Corporate Officer/Principal | - | - |
David Sesin
PRN | Corporate Officer/Principal | - | - |
Steven King
PRN | Corporate Officer/Principal | 66 | 01-01-04 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06-06-13 |
James Bochnowski
CHM | Chairman | 80 | 01-02-14 |
John Micek
BRD | Director/Board Member | 71 | 01-04-16 |
Jonathan Siegel
BRD | Director/Board Member | 50 | 29-03-18 |
Director/Board Member | 67 | 01-07-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 9 | 0 | 0 | 92,62 % |
Aandeel B | 1 | 293 353 560 | 271 699 611 ( 92,62 %) | 0 |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,63% | 115 mld. | |
+13,17% | 107 mld. | |
-12,76% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-7,19% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+6,67% | 14,26 mld. | |
+33,90% | 12,37 mld. | |
-28,60% | 8,28 mld. |